Metro Healthcare Berhad (KLSE:METRO)

Market Cap	200.68M -6.8%
Revenue (ttm)	51.12M +6.7%
Net Income	6.86M +170.5%
EPS	0.01 +192.3%
Shares Out	978.91M
PE Ratio	29.27
Forward PE	n/a
Dividend	0.01 (2.50%)
Ex-Dividend Date	Apr 6, 2026

Volume	398,900
Open	0.2100
Previous Close	0.2100
Day's Range	0.2000 - 0.2100
52-Week Range	0.2000 - 0.2450
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 23, 2026

About Metro Healthcare Berhad

Metro Healthcare Berhad, together with its subsidiaries, provides hospital and related services in Malaysia. It offers inpatient; outpatient; and ambulatory care, including in vitro fertilization (IVF), intrauterine insemination (IUI), blastocyst culture, surgical sperm retrieval, preimplantation genetic screening (PGT), and assisted hatching services. The company also provides fertility services, such as assisted reproductive technology and specialized fertility procedures; and obstetrics services that include pre-pregnancy screening and couns...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1989
• Employees: 204
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: METRO

Financial Performance

In 2025, Metro Healthcare Berhad's revenue was 50.42 million, an increase of 3.63% compared to the previous year's 48.65 million. Earnings were 5.86 million, an increase of 28.56%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 3, 2026

Data Sources Report a data error